孕期抑郁与抗抑郁药使用及母婴不良结局的系统综述与荟萃分析
该系统综述与荟萃分析纳入166项纵向队列研究、共51,596,405名参与者,评估孕期抗抑郁药暴露与抑郁对20项母婴结局的影响。抗抑郁药暴露妊娠相比所有未暴露妊娠,多数(16/20)不良结局风险升高;调整抑郁后,部分结局在未治疗抑郁妊娠中仍显著,而治疗抑郁孕妇仅早产和NICU入住风险升高。结论提示许多药物相关不良结局可能归因于潜在抑郁本身而非抗抑郁药。
要点
- 抗抑郁药暴露妊娠相比所有未暴露妊娠,16/20项不良结局风险升高。
- 调整抑郁后,部分不良结局在未治疗抑郁妊娠中仍显著。
- 治疗抑郁孕妇相比未治疗抑郁孕妇,仅早产和NICU入住风险升高。
核心结论
- 许多与药物相关的不良结局可能归因于潜在抑郁本身而非抗抑郁药。
- 应更关注抑郁,健康专业人员在咨询和产前保健中应综合评估抑郁与抗抑郁药风险。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed和Embase从建库至2025年7月29日的纵向队列研究。
- 纳入166项研究,共51,596,405名参与者,评估20项不良健康结局(6项母亲结局和14项儿童结局)。
- 使用纽卡斯尔-渥太华量表评估纳入研究的方法学质量。
主要发现
- 抗抑郁药暴露妊娠与所有未暴露妊娠(伴或不伴抑郁)相比,多数(16/20)关注的不良结局风险升高。
- 调整抑郁后,部分不良结局在未治疗抑郁妊娠中仍显著。
- 治疗抑郁孕妇相比未治疗抑郁孕妇,仅早产和NICU入住风险升高。
临床怎么用
- 产前保健和咨询中应综合评估孕期抑郁与抗抑郁药的风险,不应仅关注药物暴露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Antidepressant use during pregnancy has been increasing in the last few decades. A substantial body of evidence has indicated the increased risks of adverse health outcomes for both pregnant women and their offspring. The association may be biased by uncontrolled confounding of maternity depression or mental health status. We performed a systematic review and meta-analysis to generate comprehensive estimates of the association between depression, antidepressants, and reproductive outcomes. METHODS: The PubMed and Embase were searched from database inception to Jul 29, 2025, for longitudinal cohort studies of pregnant women with exposure to antidepressant or depression. The Newcastle-Ottawa Scale was used for assessing the methodological quality of included studies. Pooled estimates of risk ratio (RR) were calculated by comparing adverse outcomes between antidepressant-exposed pregnancies and unexposed pregnancies. Subsequently, we analyzed the risks of antidepressant-treated, untreated antenatal depression by adjusting for disease factors. Totally, 20 adverse health outcomes including 6 maternal and 14 children's outcomes were accessed. RESULTS: A total of 166 studies with 51,596,405 participants were included. When antidepressant-exposed pregnancies were compared to all unexposed pregnancies (with and without depression), an increased risk for the majority (16/20) of the focused adverse outcomes was found. After adjusting for depression, results shows that certain adverse outcomes remained significant among untreated pregnancies. However, compared with untreated depressed women, the treated by antidepressant for depressed women during pregnancy was associated with the increased risk for limited outcomes of preterm birth and NICU admission. CONCLUTION: The findings indicated that many of the adverse outcomes observed with medication may be attributable to the underlying depression itself rather than of antidepressants. More attention should be paid to depression, and health professionals should estimate the risk of depression and antidepressant comprehensively during counseling and prenatal health care.
引用
- Liu T, Zeng N, Xu Y, et al. Depression and antidepressant use in pregnancy and adverse maternal and offspring outcomes: a systematic review and meta-analysis. Mol Psychiatry. 2025. PMID: 41039087. doi:10.1038/s41380-025-03263-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。